These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8380297)

  • 1. In-vitro activity of peritoneal cells from rats after intra-abdominal infection with Bacteroides fragilis and Escherichia coli.
    Verweij WR; Namavar F; Schouten WF; Kostense PJ; Pellenkoft M; De Graaff J; MacClaren DM
    J Med Microbiol; 1993 Jan; 38(1):13-8. PubMed ID: 8380297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migration of rat peritoneal cells after intra-abdominal infection with Bacteroides fragilis and Escherichia coli.
    Verweij WR; Namavar F; Schouten WF; de Graaff J; MacLaren DM
    J Gen Microbiol; 1993 Aug; 139(8):1739-44. PubMed ID: 8409916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early events after intra-abdominal infection with Bacteroides fragilis and Escherichia coli.
    Verweij WR; Namavar F; Schouten WF; MacLaren DM
    J Med Microbiol; 1991 Jul; 35(1):18-22. PubMed ID: 2072375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Escherichia coli and Bacteroides fragilis on peritoneal host defenses.
    Dunn DL; Barke RA; Ewald DC; Simmons RL
    Infect Immun; 1985 May; 48(2):287-91. PubMed ID: 3886544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model.
    Rotstein OD; Kao J; Houston K
    J Med Microbiol; 1989 Aug; 29(4):269-76. PubMed ID: 2668529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
    Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
    Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrin in peritonitis. IV. Synergistic intraperitoneal infection caused by Escherichia coli and Bacteroides fragilis within fibrin clots.
    Dunn DL; Rotstein OD; Simmons RL
    Arch Surg; 1984 Feb; 119(2):139-44. PubMed ID: 6365029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of an atypical interferon by bacteroides fragilis and Escherichia coli in experimental infections and in leukocyte cultures.
    Blanchard DK; Rodloff AC; Steward WE; Hahn H; Friedman H
    Infection; 1986; 14(6):289-93. PubMed ID: 2434431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A standardised and reproducible model of intraabdominal infection and abscess formation in rats.
    Bosscha K; Nieuwenhuijs VB; Gooszen AW; van Duijvenbode-Beumer H; Visser MR; Verweij WR; Akkermans LM
    Eur J Surg; 2000 Dec; 166(12):963-7. PubMed ID: 11152259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination patterns of Escherichia coli and bacteroides fragilis from the peritoneal cavity. Studies with experimental peritonitis in pigs.
    Nyström PO; Skau T
    Acta Chir Scand; 1983; 149(4):383-8. PubMed ID: 6351520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of phagocytosis of E. coli by B. fragilis group--an in vitro study.
    Beena VK; Kumari N; Shivananda PG
    Indian J Pathol Microbiol; 1997 Jul; 40(3):373-6. PubMed ID: 9354011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kinetics of peritoneal clearance of Escherichia coli and Bacteroides fragilis and participating defense mechanisms.
    Skau T; Nyström PO; Ohman L; Stendahl O
    Arch Surg; 1986 Sep; 121(9):1033-9. PubMed ID: 3527110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between polymorphonuclear leucocytes, Bacteroides sp, and Escherichia coli: their role in the pathogenesis of mixed infection.
    Vel WA; Namavar F; Verweij-van Vught AM; Pubben AN; MacLaren DM
    J Clin Pathol; 1986 Apr; 39(4):376-82. PubMed ID: 3517072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy of Bacteroides fragilis and Escherichia coli in the induction of KC gene expression in mouse peritoneal tissues.
    Kim JM; Kim YJ; Cho YJ
    Scand J Infect Dis; 2000; 32(6):643-9. PubMed ID: 11200375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of anti-Bacteroides-antibodies on Escherichia coli and different Bacteroides species in vitro and vivo.
    Rodloff AC; Hilliger F; Friedman H; Hahn H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Nov; 262(4):483-91. PubMed ID: 3541458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lethal microbial synergism in intra-abdominal infections. Escherichia coli and Bacteroides fragilis.
    Rotstein OD; Pruett TL; Simmons RL
    Arch Surg; 1985 Feb; 120(2):146-51. PubMed ID: 3156575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient and distant infections alter later intraperitoneal abscess formation.
    Sawyer RG; Adams RB; Spengler MD; Pruett TL
    Arch Surg; 1991 Feb; 126(2):164-8. PubMed ID: 1992993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization-induced changes in later intra-abdominal abscess formation are mediated by cellular and humoral mechanisms.
    Sawyer RG; Adams RB; Spengler MD; Pruett TL
    Curr Surg; 1990; 47(5):331-4. PubMed ID: 2257748
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
    Brook I
    J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of laparoscopic models on anaerobic bacterial growth with bacteroides fragilis in experimentally induced peritonitis.
    Sare M; Demirkiran AE; Tastekin N; Durmaz B
    J Laparoendosc Adv Surg Tech A; 2003 Jun; 13(3):175-9. PubMed ID: 12855099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.